Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      21 trials found for breast cancer

      Recruiting
      Not yet recruiting
      Recruiting
      NCT06157892
      A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

      Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast

      Male or Female
      18+ years
      123study location(s)
      Recruiting
      NCT04389632
      A Study of Sigvotatug Vedotin in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      131study location(s)
      Recruiting
      NCT05226871
      Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

      Breast Cancer, Head and Neck Cancer

      Male or Female
      18+ years
      22study location(s)
      Recruiting
      NCT04557449
      Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

      Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

      Male or Female
      18+ years
      38study location(s)
      Recruiting
      NCT06465368
      A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

      Breast Cancer

      Females
      18+ years
      28study location(s)
      Recruiting
      NCT03445637
      Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

      Breast Neoplasm

      Females
      18+ years
      1study location(s)
      Recruiting
      NCT04654208
      Swedish Ibrance Registries Insights (SIRI)

      Malignant Neoplasm of Breast

      Male or Female
      18 - 99 years
      1study location(s)
      Recruiting
      NCT04937660
      Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

      Metastatic Breast Cancer

      Male or Female
      18 - 90 years
      12study location(s)
      Dec 01, 2026 - Planned start date (Not yet recruiting)
      NCT06873191
      A Study to Learn More About Tukysa Once it is Out in the Korean Market

      HER2-positive Locally Advanced Unresectable, Metastatic Breast Cancer

      Male or Female
      18+ years
      Dec 31, 2025 - Planned start date (Not yet recruiting)
      NCT04982848
      Korea Post Marketing Surveillance (PMS) Study of Talzenna®

      Breast Neoplasms

      Male or Female
      19+ years

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.